Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis

NCT00116649 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
551
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Graceway Pharmaceuticals, LLC